Laurus Labs is committed to conducting its business with the highest standards of integrity, with the Board providing indispensable leadership.
The corporate governance framework at Laurus Labs is based on an effective independent Board, separation of the Board’s supervisory role from the executive management team, constitution of the Board committees and formulation of policies, each as required under law, including SEBI Listing Regulations.
We comply fully with the requirements of applicable regulations, including the SEBI Listing Regulations, the Companies Act, and the SEBI ICDR Regulations, in respect of corporate governance. Currently, the board has 10 Directors, headed by the Chairman who is a non-executive and independent director.
We have four Executive Directors, six Non-Executive Directors including five Independent Directors on the Board. Our Board also has one woman Director. The Board functions directly or through various committees constituted to oversee specific operational areas. The executive management reports regularly on the company’s performance.
- Dr. M Venu Gopala Rao
-
Non-Executive Chairman/Independent Director
- Dr. Chava Satyanarayana
-
CEO/Executive Director
- Dr. Lakshman Chunduru
-
Executive Director – Quality
- Mr. Venkata Ravi Kumar Vantaram
-
CFO/ Executive Director
- Mr. Chandrakanth Chereddi
-
Non-Executive Director
- Mrs. Aruna Bhinge
-
Non-Executive Director/Independent Director
- Mr. Rajesh Koshy Chandy
-
Non-Executive Director/Independent Director
- Dr. Ravindranath Kancherla
-
Non-Executive Director/Independent Director
Policy of Prohibition of Child, Adolescent, Forced Labour
Business Code of Conduct and Ethics Policy
Criteria for determining materiality of events
Code for Prohibition of Insider Trading
Corporate Social Responsibility Policy
Familiarization Programmes for Independent Directors
Policy on Materiality of Subsidiaries
FY-2023
FY-2023
Annual Secretarial Compliance Report for the year ended March 31, 2023
Regulation 13(3) - Investors’ Grievances report for the period from 01.01.2023 to 31.03.2023
Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015
Initial Disclosure under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26,2018
Annual Disclosure under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018
FY-2022
FY-2021
Statement of investor complaints during the quarter ended 31st december 2020
Laurus Labs Limited Corporate Governance Report -3rd Quarter
Disclosure of Related! Party Transactions for the period ended 31.03.2021
Annual Secretarial Compliance Report for the year ended 31.03.2021
Certificate under Regulation 40(9) of SEBI (LQDR) Regulations 2015
Investors’ Grievances report for the period from 01.01.2021 to 31.03.2021
Committees of Board
Committees of Board
FY-2020
Certificate under Regulation 74(5) of the SEBI Regulations, 2018 for the quarter ended June 30,2019
Certificate under Regulation 76 of SEBI Regulations 2018
Corporate Governance Q2 2019-20
Investor Grievance Report Q2 2019-20
Laurus Labs Reg 7(3) certificat 30-09-2019
Laurus Labs Reg 74 certificate 30 09 2019
Laurus Labs Reconciliation Of Share Capital Audit 30 09 2019
Laurus Labs Reg 40(9)30 09 2019
FY-2019
Reconciliation of Share Capital Audit
LaurusLabs Certificate Regulation 40(9) Q2 FY 2018-19
FY-2018
Investor Compliants Report Q2 2017-18
Reconciliation of Share Capital Audit Q2 2017-18
Compliance Certificate Reg 7(3) of SEBI LODR Q2 2017-18
FY-2017
Re-appointment Letter of Dr. MVG Rao
Re-appointment Letter of Dr. Ravindranath Kancherla
Re-appointment Letter of Mrs. Aruna Bhinge
Re-appointment Letter of Dr. Rajesh Chandy
Dr. Rajesh Koshy Chandy - Appointment Letter
Mrs. Aruna Bhinge - Appointment Letter


During the year, the Company has inducted three independent directors on the Board. The Company has arranged a special induction/familiarization program to these three directors wherein these three directors have made a two-day visit in November 2016 to its Corporate Office and its R&D Plant at Hyderabad, its manufacturing facilities at Visakhapatnam and interacted with all senior colleagues including the whole time directors of the Company. During March 2017 also once again the Board meeting was conducted in Visakhapatnam and the Directors have visited all the manufacturing facilities of the Company. At the time of appointment, the CEO and some other Board members have interacted with these new independent directors and explained the objective and philosophy and core values of the Company. The Company has provided all the literature such as its previous annual reports, presentation on operations, budget vs. achievements etc. All these independent directors have been provided with the letters of appointments wherein their duties, roles and expectations of the Company etc. have been clearly specified.
Apart from the above, senior management personnel of the Company regularly make presentations to the Board members on the operations of the Company, its plans, strategy, risks involved, new initiatives etc. and seek their views and suggestions on the same. The Board members have been provided with various policies of the Company including Code of Conduct for Directors and Senior Management Personnel etc.
Discover more
Laurus Labs 16th Annual General Meeting (AGM) held on 15 July, 2021